Enerflex Ltd. Announces Timing of First Quarter Financial and Operational Results and Schedules Virtual Investor Update

CALGARY, Alberta, April 21, 2026 (GLOBE NEWSWIRE) — Enerflex Ltd. (TSX: EFX) (NYSE: EFXT) (“Enerflex” or the “Company”) plans to release its financial results and operating highlights for the three months ended March 31, 2026, on Thursday, May 7, 2026 prior to market open. Results will be communicated by news release and will be available on the Company’s website at www.enerflex.com and under the electronic profile of the Company on SEDAR+ and EDGAR at www.sedarplus.ca and www.sec.gov/edgar, respectively.

Investors, analysts, members of the media, and other interested parties, are invited to participate in a conference call and audio webcast on Thursday, May 7, 2026 at 8:00 a.m. (MT), where members of senior management will discuss the Company’s results. A question-and-answer period will follow.

To participate, register at https://register-conf.media-server.com/register/BI6515d65feedd4a68be887d88f452621e. Once registered, participants will receive the dial-in numbers and a unique PIN to enter the call. The audio webcast of the conference call will be available on the Enerflex website at www.enerflex.com under the Investors section or can be accessed directly at https://edge.media-server.com/mmc/p/jpr3iwfx.


Virtual Investor Update

Enerflex will host a virtual Investor Update on Wednesday, May 27, 2026 at 8:00 am MT (10:00am ET). Enerflex’s President and CEO, Paul Mahoney, will highlight the Company’s outlook and strategic priorities with a question and answer period to follow.

Registration for the Virtual Investor Update can be made using the following https://edge.media-server.com/mmc/p/eyz29mbq. Participants can join by webcast to follow along with the presentation. The presentation will be made available on Enerflex’s website prior to the start. Questions can be submitted via the webcast or asked on the dial-in:

Dial-in numbers: https://register-conf.media-server.com/register/BI8e02cded3fae4a3dbb8d89234ae4be38.

Shortly after the live webcast, an archived version will be available on Enerflex’s website.

ADVISORY REGARDING FORWARD-LOOKING INFORMATION
This news release contains “forward-looking information” within the meaning of applicable Canadian securities laws and “forward-looking statements” (and together with “forward-looking information”, “FLI”) within the meaning of the safe harbor provisions of the US Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are FLI. In particular, this news release includes (without limitation) FLI pertaining to the Company’s expectation to release its financial results and operating highlights for the three months ended March 31, 2026, on Thursday, May 7, 2026 prior to market open; and the Company’s intention to host a virtual Investor Update on Wednesday, May 27, 2026, and the expected content of such update.

The FLI included in this news release is made as of the date of this news release and is based on the information available to the Company at such time and, other than as required by law, Enerflex disclaims any intention or obligation to update or revise any FLI, whether as a result of new information, future events, or otherwise. This news release and its contents should not be construed, under any circumstances, as investment, tax, or legal advice.

ABOUT ENERFLEX
Enerflex is a leading provider of modular natural gas, power, and treated water technology solutions, delivering value through disciplined execution and a deliberate approach to where we compete. Our customer focused delivery model supports operational excellence, innovation, and scalability across our global footprint with a focus on creating long-term shareholder value.

With approximately 4,400 engineers, manufacturers, technicians, professionals, and innovators, Enerflex is bound together by a shared vision: Transforming Energy for a Sustainable Future. The Company remains committed to the future of natural gas and the critical role it plays, while focused on sustainability offerings to support the world’s energy needs.

Enerflex’s common shares trade on the Toronto Stock Exchange under the symbol “EFX” and on the New York Stock Exchange under the symbol “EFXT”. For more information about Enerflex, visit www.enerflex.com.

For investor and media enquiries, contact:

Paul Mahoney
President and Chief Executive Officer
E-mail: [email protected]

Preet S. Dhindsa
Senior Vice President and Chief Financial Officer
E-mail: [email protected]

Jeff Fetterly
Vice President, Corporate Development and Capital Markets
E-mail: [email protected]



Navan 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Navan, Inc. – NAVN

Navan 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Navan, Inc. – NAVN

NEW YORK & NEW ORLEANS–(BUSINESS WIRE)–Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until April 24, 2026 to file lead plaintiff applications in a securities class action lawsuit against Navan, Inc. (“Navan” or the “Company”) (NasdaqGS: NAVN), if they purchased or otherwise acquired the Company’s shares pursuant and/or traceable to the Registration Statement and Prospectus (collectively, the “Offering Documents”) issued in connection with Navan’s October 2025 initial public offering (the “IPO”). This action is pending in the United States District Court for the Northern District of California.

What You May Do

If you purchased shares of Navan and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgs-navn/ to learn more. If you wish to serve as a lead plaintiff in this class action by overseeing lead counsel with the goal of obtaining a fair and just resolution, you must request this position by application to the Court by April 24, 2026.

About the Lawsuit

According to the Complaint, Navan and certain of its executives are charged with failing to disclose material information in the Offering Documents, violating federal securities laws. The alleged false and misleading statements and omissions include, but are not limited to, that the Company had increased its “sales and marketing” expenses for the quarter ending October 31, 2025 to nearly $95 million, or by 39% compared to $68.5 million sales and marketing expenses in the quarter ending July 31, 2025. When the true details entered the market, the lawsuit claims that the Company’s shares fell sharply.

The case is McCown v. Navan, Inc., Case No. 26-cv-01550.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors – in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.

TOP 10 Plaintiff Law Firms – According to ISS Securities Class Action Services

To learn more about KSF, you may visit www.ksfcounsel.com.

CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected]
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163

KEYWORDS: Louisiana United States North America

INDUSTRY KEYWORDS: Class Action Lawsuit Professional Services Legal

MEDIA:

Logo
Logo

Leading Independent Proxy Advisory Firm Glass Lewis Supports Impactive’s Case for Change at WEX

Leading Independent Proxy Advisory Firm Glass Lewis Supports Impactive’s Case for Change at WEX

Glass Lewis Recommends Shareholders Vote FOR Impactive Nominees Kurt Adams and Lauren Taylor Wolfe and WITHHOLD Support on WEX Board Chair and CEO Melissa Smith and Compensation Committee Chair Stephen Smith

Concludes that Separation of CEO and Chair Role is in Shareholders’ Interests in Light of Sustained Underperformance Under Melissa Smith’s Tenure

Determines Impactive Has “Articulated a Coherent Set of Concerns Regarding Oversight and Capital Allocation”

Impactive Urges Shareholders to Vote on the WHITE Proxy Card to Elect All Three of Its Highly Qualified Nominees

NEW YORK–(BUSINESS WIRE)–
Impactive Capital, LP (“Impactive” or “we”), together with its affiliates, is one of the largest shareholders of WEX Inc. (NYSE: WEX) (the “Company” or “WEX”) with an ownership interest of approximately 4.9%. Impactive announced today that leading proxy advisory firm Glass, Lewis & Co. (“Glass Lewis”) has recommended that shareholders vote on the WHITE proxy card FOR the election of Impactive director nominees Kurt Adams and Lauren Taylor Wolfe to the Company’s Board of Directors (the “Board”) and WITHHOLD on Board Chair and CEO Melissa Smith and director and Compensation Committee Chair Stephen Smith.

Impactive stated:

“We appreciate Glass Lewis’ recognition of the merits of our case for change and its recommendation that shareholders vote to elect Kurt Adams and Impactive principal and significant shareholder representative Lauren Taylor Wolfe to WEX’s Board. Glass Lewis’ report is unequivocal: WEX’s persistent underperformance, poor capital allocation, and insufficient Board oversight demand new voices in the boardroom — directors aligned with shareholders and accountable for results. Glass Lewis’ recommendation to separate the Chair and CEO roles by withholding support from Melissa Smith is particularly notable, highlighting the critical importance of reversing the Company’s prolonged underperformance and governance shortcomings. Electing all three of our highly qualified nominees is the most effective path to strengthening oversight, improving capital allocation, and positioning WEX to deliver sustainable shareholder value.”

In its report, Glass Lewis supported Impactive’s case for change, writing:1

  • “[Impactive] has articulated a credible case for enhanced oversight, and the performance record, while not uniformly negative, reflects a sustained period of relative underperformance against the most relevant comparators over long- and medium-term horizons that the Company has not fully rebutted through its operational narrative.”

  • “Given that [Impactive’s] campaign has demonstrated credibility, appears to have contributed to a more favorable market reassessment, and has articulated a coherent set of concerns regarding oversight and capital allocation, shareholders are justified in concluding that direct Impactive representation on the board is appropriate.”

Glass Lewis commented on the qualifications of Impactive’s nominees:

  • “[Lauren Taylor Wolfe’s] direct involvement in the campaign and investment thesis provides clear alignment with the perspectives advanced in support of change, as well as detailed familiarity with the Company’s strategy, performance, and perceived areas of improvement.”

  • “[Kurt Adams] brings relevant financial services, regulatory, and governance experience that appears additive to the board, and his independence from both the Company and [Impactive] should enable him to contribute constructively while reinforcing board accountability.”

In making its recommendation to withhold on Melissa Smith and Stephen Smith, Glass Lewis wrote the following:

  • “The combination of the chair and CEO roles, the level of shareholder dissent observed in 2025, and the Company’s sustained underperformance over [Melissa Smith’s] tenure as chair together support the conclusion that greater separation between executive leadership and board oversight is in shareholders’ interests.”

  • “In this context, it is relevant that [Impactive’s] proposal relates to Ms. Smith’s position as chair, rather than her executive role. Should she not be re-elected to the board, Ms. Smith would continue to serve as CEO.”

  • “… [Impactive] has articulated a range of governance and performance-related concerns … with respect to leadership accountability, compensation oversight, and board responsiveness. These concerns appear most directly attributable to Melissa Smith, given her combined executive and board leadership role.”

  • “As chair of the Compensation Committee, [Stephen Smith] bears direct responsibility for a compensation framework that the Dissident has credibly argued has not adequately reflected shareholder experience over the relevant period.”

Glass Lewis commented on WEX’s poor corporate governance underscored by low shareholder support at the 2025 AGM, stating:

  • “The level of shareholder dissent observed at the 2025 annual meeting, particularly with respect to the Company’s leadership, suggests that the Dissident’s concerns resonated with a meaningful portion of the shareholder base and that a degree of board-level accountability is warranted.”

  • “…Ms. Smith received more than 30% votes against her re-election in 2025, which constitutes a significant level of shareholder opposition. This outcome followed the Dissident’s 2025 campaign opposing her re-election, suggesting that the level of dissent may, at least in part, reflect shareholder alignment with the concerns advanced by the Dissident. Under prevailing market standards, dissent exceeding 20% is generally viewed as a meaningful signal of investor concern.”

For more information, including how to vote for Impactive’s three nominees using the WHITE proxy card, please visit www.WakeUpWEX.com.

If you have any questions, require assistance in voting your WHITE universal proxy card, or need additional copies of Impactive’s proxy materials, please contact:

 

Okapi Partners LLC

1212 Avenue of the Americas, 17th Floor

New York, New York 10036

Stockholders may call toll-free: (877) 285-5990

Banks and Brokers call: (212) 297-0720

E-mail: [email protected]

ADDITIONAL INFORMATION

Impactive Capital Master Fund LP, together with the other participants in its proxy solicitation (collectively, “Impactive”), has filed a definitive proxy statement and accompanying WHITE universal proxy card with the Securities and Exchange Commission (“SEC”) to be used to solicit proxies with respect to the election of Impactive’s slate of highly qualified director candidates and the other proposals to be presented at the 2026 annual meeting of stockholders (the “Annual Meeting”) of WEX Inc., a Delaware corporation (“WEX” or the “Company”). Stockholders are advised to read the proxy statement and any other documents related to the solicitation of stockholders of the Company in connection with the Annual Meeting because they contain important information, including information relating to the participants in Impactive’s proxy solicitation. These materials and other materials filed by Impactive with the SEC in connection with the solicitation of proxies are available at no charge on the SEC’s website at http://www.sec.gov. The definitive proxy statement and other relevant documents filed by Impactive with the SEC are also available, without charge, by directing a request to Impactive’s proxy solicitor, Okapi Partners LLC, at its toll-free number (877) 285-5990 or via email at [email protected].

____________________

1 Permission to quote Glass Lewis was neither sought nor received. Emphasis added.

Investor Contacts:

Bruce Goldfarb / Chuck Garske / Lisa Patel

Okapi Partners

(877) 285-5990

[email protected]

OR

[email protected]

Media Contact:

Longacre Square Partners

[email protected]

KEYWORDS: New York United States North America

INDUSTRY KEYWORDS: Asset Management Professional Services Finance

MEDIA:

Shoals Technologies Group, Inc. Announces Participation in Upcoming Events for the Investor Community

PORTLAND, Tenn., April 21, 2026 (GLOBE NEWSWIRE) — Shoals Technologies Group, Inc. (“Shoals” or the “Company”) (Nasdaq: SHLS), a global leader in electrical infrastructure solutions for the energy transition market, announced today its participation in the following upcoming investor events:

May 7, 2026: JP Morgan Virtual Fireside Chat

Shoals’ CEO, Brandon Moss, and CFO, Dominic Bardos, will participate in a fireside chat with covering analyst Mark Strouse. Interested investors should contact their JP Morgan sales representative.

May 13, 2026: Johnson Rice Virtual Fireside Chat

Shoals’ VP of Finance & Investor Relations, Matt Tractenberg, and SVP of Sales, Karen Bazela, will participate in a fireside chat with covering analyst Marty Malloy. Interested investors should contact their Johnson Rice sales representative.

May 27, 2026: Bank of America Power, Utilities and Cleantech Conference in New York

Shoals’ CFO, Dominic Bardos, and Investor Relations Manager, Corbin Smith, will host in-person investor meetings. Interested investors should contact their Bank of America sales representative.

May 28, 2026: TD Cowen Technology, Media & Telecom Conference in New York

Shoals’ CFO, Dominic Bardos, SVP of Sales, Karen Bazela, and Investor Relations Manager, Corbin Smith, will host in-person investor meetings. Interested investors should contact their TD Cowen sales representative.

June 2, 2026: RBC Global Energy, Power & Infrastructure Conference in New York

Shoals’ VP of Finance & Investor Relations, Matt Tractenberg, and Senior Director of Business Development, Ed Lo Bianco, will host in-person investor meetings. Interested investors should contact their RBC sales representative.

June 17, 2026: Roth Conference in London

Shoals’ VP of Finance & Investor Relations, Matt Tractenberg, and VP of Marketing & External Communications, Lindsey Williams, will host in-person investor meetings. Interested investors should contact their Roth sales representative.

June 24, 2026: JP Morgan Natural Resources Conference in New York

Shoals’ CEO, Brandon Moss, and VP of Finance & Investor Relations, Matt Tractenberg, will host in-person investor meetings. Interested investors should contact their JP Morgan sales representative.

June 25, 2026: UBS Virtual Fireside Chat

Shoals’ CFO, Dominic Bardos, and VP of Finance & Investor Relations, Matt Tractenberg, will participate in a fireside chat with covering analyst Jon Windham. Interested investors should contact their UBS sales representative.

About Shoals Technologies Group, Inc.

Shoals Technologies Group is a leading manufacturer of advanced electrical infrastructure solutions for mission-critical applications across utility‑scale solar, battery storage, and data center power systems. Since its founding in 1996, the Company has designed innovative technologies and systems solutions that allow its customers to substantially increase installation efficiency and safety while improving system performance and reliability at scale. Shoals Technologies Group is a recognized leader in the energy transition industry. For additional information, please visit: https://www.shoals.com.

Contacts:

Investor Relations:

Matt Tractenberg, VP of Finance and Investor Relations
Email: [email protected]

Media:

Lindsey Williams, VP of Marketing and External Communications
Email: [email protected]



Aeroméxico Reports Unaudited First Quarter 2026 Results

  • Total Revenue growth of 13% year-on-year
  • Adjusted EBITDAR Margin of 25%
  • Operating Margin of 11%
  • Liquidity to LTM Revenue ratio at 23%

MEXICO CITY, April 21, 2026 (GLOBE NEWSWIRE) — Grupo Aeroméxico S.A.B. de C.V. (NYSE: AERO & BMV: AERO, “Aeroméxico” or the “Company”) today reported unaudited consolidated financial results for the three months ended March 31, 2026 (“1Q26”). These results are based on information available to us as of the date of this earnings release and are not a comprehensive statement of our financial results for the period presented. The Company has used the U.S. dollar, its functional currency, as the presentation currency for its consolidated financial statements. All figures are expressed in millions of U.S. dollars unless otherwise indicated.

Andrés Conesa, Chief Executive Officer stated: “Aeroméxico started 2026 on a solid footing, building on the momentum gained in the second half of 2025. Demand remained robust during the quarter, supporting strong revenue performance despite a dynamic environment and temporary disruptions in specific local markets. While higher fuel prices have put pressure on margins, our disciplined approach to capacity and network management, commitment to premium revenue strategies, pricing initiatives, and cost control, allowed us to sustain solid profitability. Operationally, we continued to demonstrate high levels of reliability, once again being recognized by Cirium as the world’s most on-time airline for the first quarter of 2026. These results reflect the resilience of our business model and the exceptional commitment of our people, as we remain focused on safety, profitability, and delivering a superior customer experience—reinforcing our position as Mexico’s flagship carrier.”

OPERATING & FINANCIAL HIGHLIGHTS FIRST QUARTER 2026

  • Capacity, measured in available seat miles (ASMs), decreased by 1.2% year-over-year in 1Q26.
  • Total revenue reached $1.3 billion, a 13.3% increase as compared to the same period of 2025.
  • Adjusted EBITDAR

    (


    1


    )
    totaled $335.8 million, with a 25.0% margin, marking a 5.0% increase over the same period last year.
  • Operating income totaled $141.8 million, with a 10.6% margin.
  • Cost per ASM
    excluding fuel (CASM-Ex), was 10.2¢.
  • Total adjusted net debt to EBITDAR(1) ended the quarter at 1.7x, compared to 1.8x in 4Q25.
  • Liquidity

    (2)
    reached $1.2 billion and represented 23.0% of total revenues.

2Q26 OUTLOOK

Indicator 2Q26 Guidance
Total Capacity (ASMs) ~ 1.5% to 2.5%
Total Revenue ~ 1.47 bn to 1.52 bn
Total Revenue YoY ~ 12.5% to 15.5%
Adjusted EBITDAR Margin ~ 17.0% to 20.0%
Operating Income Margin ~ 4.0% to 7.0%



KEY FINANCIAL AND OPERATING HIGHLIGHTS FOR THE

FIRST
QUARTER
2026

Key Financial KPIs
Three Months Ended March 31
1Q26 1Q25 Var. %
Total revenue (USD millions) 1,341 1,184 13.3%
Adjusted EBITDAR(1) (USD millions) 336 320 5.0%
Adjusted EBITDAR margin(1) (% of Revenue) 25% 27% (2.0 p.p.)
Total operating income (loss) (USD millions) 142 142 (0.1%)
Operating margin (% of Revenue) 11% 12% (1.4 p.p.)
Key Operating Indicators 1Q26 1Q25 Var. %
Total ASMs (millions) 8,596 8,697 (1.2%)
Passengers (‘000) 5,791 5,877 (1.5%)
Total revenue / ASM (USD cents) 15.6 13.6 14.6%
Total cost / ASM (USD cents) 13.8 11.9 16.0%
Total cost excluding fuel / ASM (USD cents) 10.2 8.6 17.8%
Foreign Exchange* 1Q26 1Q25 Var. %
Average 17.58 20.43 (14.0%)

Figures may not sum to total due to rounding.

*Source: Company with information from Banxico.



INCOME STATEMENT DISCUSSION

1Q 2026 Revenue

Total revenue for the first quarter of 2026 reached $1.3 billion, representing a 13.3% year-over-year increase. This growth was driven by our continuous focus on premium revenue(2), the sustained recovery in demand that began in the latter half of 2025, and the strengthening of the Mexican peso, contributing to robust revenue performance during the quarter.

Our premium revenue(3) mix climbed to 42% of passenger-related revenue, up from 41% in 1Q25, demonstrating strong demand for higher-yield services across our network. These overall results reflect demand resilience, notwithstanding localized disruptions in February that affected certain regions in Mexico and transborder markets originating in the United States.

Total revenue per Available Seat Mile (“TRASM”) reached 15.6¢, marking a 14.6% year-over-year increase. The upward trend in TRASM was largely attributed to a 2.2 percentage point improvement in load factor, an increase of over $100.0 million in both domestic and international passenger revenue, and the appreciation of the Mexican peso. ASM volume decreased by 1.2%, reflecting disciplined capacity management, with domestic capacity down 2.8% compared to the previous year.

The following table shows our total revenue breakdown during the indicated periods:

Total Revenue

(USD million)
Three months ended

March 31
2026 2025 Var. %
Domestic 494 438 12.7%
International 847 746 13.6%
Total revenue 1,341 1,184 13.3
%

Figures may not sum to total due to rounding.



1Q 2026 Operating Expenses

In 1Q26, total operating expenses –including fuel, labor, maintenance, passenger and aircraft services, aircraft leases, depreciation and amortization– reached $1.2 billion, a 15.1% increase compared to 1Q25. The increase was primarily driven by the impact of the Mexican peso’s appreciation on peso-denominated expenses, inflation in wages, salaries, and benefits, increased depreciation and amortization associated with the fleet expansion in 2025, and elevated fuel prices triggered by global geopolitical events since late February.

Fuel cost per liter increased 13.1% compared to 1Q25, averaging 77¢ per liter in 1Q26 compared to 68¢ per liter in 1Q25. Fuel consumption decreased by 2.6% year-over-year, while fuel burn per ASM (liters of fuel consumed per ASM) decreased by 1.4%, mainly due to a more efficient fleet mix.

Cost per AS
M excluding fuel (CASM-Ex) was 10.2¢ in 1Q26, representing an increase of 17.8% compared to the same period in 2025. This rise was primarily driven by a 14.0% appreciation of the Mexican peso, increased ownership costs attributable to additions to the aircraft fleet in 2025, higher labor expenses associated with inflation-related salary adjustments, and the expansion of international operations.

1Q 2026 Adjusted EBITDAR

(


1


)

and Operating Income

Adjusted EBITDAR

(


1


)
for the first quarter amounted to $335.8 million with a 25.0% margin. This result represents a 5.0% increase compared to 1Q25, notwithstanding higher fuel costs and localized demand disruptions affecting revenue in specific regions of Mexico.

Operating income for the first quarter reached $141.8 million, with a margin of 10.6%. This result corresponds with the lower end of the guidance range issued in the previous quarter.

1Q
2026
Net Financing Cost

Net financing costs increased by $14.6 million compared to the same period in 2025, primarily due to increased net foreign exchange losses. In 1Q26, foreign exchange loss grew by $6.8 million, while financial expenses increased by $7.8 million, largely reflecting higher interest expenses from lease obligations associated with fleet expansion.

1Q
2026
Net Income

Net income in 1Q26 totaled $10.7 million with a 0.8% margin.

BALANCE SHEET AND CASH FLOW

As of March 31, 2026, Aeroméxico reported cash and cash equivalents, and short-term investments totaling $1.0 billion. This is an increase of $178.0 million compared to the same quarter in the previous year and $21.0 million higher than at year-end 2025, despite the usual seasonal weakness of the quarter.
Including the $200.0 million revolving credit facility secured in 3Q24, total liquidity reached $1.2 billion. This represents a ratio of liquidity to last-twelve-month revenues of 22.6%.

In 1Q26, Aeroméxico generated $200.6 million in net cash from operating activities, which allowed the Company to continue with its investment and deleveraging programs.

During the first quarter, the Company repaid $9.3 million of financial debt.

OPERATING FLEET

During 1Q26, Grupo Aeroméxico received one Boeing 787-9 aircraft.

Aeroméxico’s operating fleet was comprised of 166 aircraft as of March 31, 2026, with an average age of 8.8 years.

  OPERATING FLEET

  Fleet 2Q25 3Q25 4Q25 1Q26
  B-737-800 34 34 34 34
  B-737 MAX 8 42 44 45 45
  B-737 MAX 9 26 28 30 30
  B-787 22 22 22 23
  Aeroméxico 124 128 131 132
           
  E-190 34 34 34 34
  Aeroméxico Connect 34 34 34 34
  Grupo Aeroméxico 158 162 165 166

Footnotes
(1) Adjusted EBITDAR, Adjusted Net Debt to EBITDAR, and Adjusted EBITDAR Margin are non-IFRS measures and have limitations as analytical tools, and you should not consider them in isolation, or as a substitute for analysis of the Company’s results as reported under IFRS. See Annex A for the definition of Aeroméxico’s non-IFRS measures and a reconciliation to the nearest IFRS measure.
(2) Liquidity is defined as cash and cash equivalents, and short-term investments.
(3) Premium revenue mix consists of revenue from premium products and services above Básica / Clásica coach cabin products. Ratio is calculated based on total passenger revenue.



1Q26 EARNINGS CALL INFORMATION

Date Wednesday, April 22, 2026

 
Time 12:30 p.m. ET (NY) / 10:30 a.m. CT (CDMX)

 
Webcast Link https://edge.media-server.com/mmc/p/ta78xgyw

 
Participant Listening*

https://register-conf.media-server.com/register/BIe78975e545c8496bb1037d726d2c3cb3

 

*Participants can complete the online registration form and upon registering will receive the dial-in info and a unique PIN to join the call.




About Grupo Aeroméxico



Grupo Aeroméxico, S.A.B. de C.V. is a holding company whose subsidiaries are engaged in commercial aviation in Mexico and the promotion of passenger loyalty programs. Aeroméxico, Mexico’s global airline, has its main operations center in Terminal 2 of the Mexico City International Airport. Its destination network has reach in Mexico, the United States, Canada, Central America, South America, Asia and Europe. The Group’s current operating fleet includes Boeing 787 and 737 aircraft, as well as the latest generation Embraer 190. Aeroméxico is a founding partner of SkyTeam, an alliance that celebrates 20 years and offers connectivity in more than 170 countries, through the 19 partner airlines. Aeroméxico created and implemented a Health and Hygiene Management System (SGSH) to protect its clients and collaborators at all stages of its operation.


www.aeromexico.com



www.skyteam.com


Forward Looking Statements


This press release contains certain forward-looking statements, within the meaning of the Private Securities Litigation Reform Act, that reflect the current views and/or expectations of the Company and its management with respect to its performance, business and future events. We use words such as “believe,” “anticipate,” “plan,” “expect,”, “intend,” “target,” “estimate,” “project,” “predict,” “guidance,” “forecast,” “guideline,” “should” and other similar expressions to identify forward-looking statements, but they are not the only way we identify such statements. Such statements are subject to a number of risks, uncertainties and assumptions. We caution you that a number of important factors could cause actual results to differ materially from the plans, objectives, expectations, estimates and intentions expressed in this release. Important factors that could cause such differences include, but are not limited to: external risks, including health threats, accidents, global instability, security breaches, terrorism and natural disasters; global geopolitical conflicts, particularly those that impact the price of jet fuel; Mexican and international economic conditions, as well as seasonality, on customer travel behavior; the current U.S.’s administration tariffs on the Company’s costs and the actions of other governmental authorities in Mexico, the U.S. and other countries; fuel market volatility; the Company’s capacity to fulfill the Company’s fixed obligations, obtain financing and/or maintain liquidity; the Company’s capacity to retain and attract key personnel and other professionals, and the Company’s labor relations with employees; the Company’s reliance on few aircraft manufacturers and other third-party providers; the Company’s aircraft utilization rate and aircraft maintenance costs; changes in landing charges, airport access fees and inadequate airport infrastructure; consumer protection restrictions; dependence on the Company’s main hub, MEX; air traffic congestion; the competitive environment in the aviation industry, including those arising from non-air travel substitutes; sanctions and compliance with anti-corruption, anti-money laundering, anti-drug trafficking and other ethical rules and standards; reliance on partnerships and alliances and challenges in entering into new ones; and other factors described in “Risk Factors” of the Company’s final prospectus dated as of November 5, 2025 relating to its initial public offering and other documents filed with or furnished to the SEC from time to time. Forward-looking statements are based on information available at the time those statements are made and/or management’s good faith belief as of that time with respect to future events. The Company is under no obligation and expressly disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.



Grupo Aeroméxico, S.A.B. de C.V. and Subsidiaries

Consolidated Statements of Profit or Loss and other Comprehensive Income (Unaudited)
  Three Months

Ended March 31

(USD millions)
       
 
2026

2025
 
Var. %
Revenues:      
Passenger 1,212 1,072   13.1 %
Air cargo 76 71   7.9 %
Other 53 41   29.0 %
Total revenue 1,341 1,184   13.3 %
       
Operating expenses:      
Jet-fuel 315 286   10.2 %
Wages, salaries and benefits 308 252   22.4 %
Maintenance 68 53   28.6 %
Aircraft, communications and traffic services 154 136   13.7 %
Passenger services 39 33   20.6 %
Travel agent commissions 22 21   8.5 %
Selling and administrative 88 80   10.7 %
Aircraft leasing 4 5   -11.6 %
Depreciation and amortization 190 173   9.7 %
Impairment (reversal)   NA
Other (income) loss, net 10 6   64.5 %
Share of gain on equity accounted investees, net of tax (1 ) NA
Total operating expenses 1,200 1,042   15.1 %
       
Total operating income 142 142   -0.1 %
Finance income (cost):      
Net finance cost 129 115   12.7 %
Income before income tax 13 27   -54.0 %
Income tax 2 6   -65.9 %
Net income for the period 11 22   -51.0 %
       

The Company has used the US dollar as the presentation currency for these consolidated financial statements, which is also its functional currency.

 
Grupo Aeroméxico, S.A.B. de C.V. and Subsidiaries
Consolidated Statements of Financial Position (Unaudited)
 
(USD Millions)
 
March 31, 2026

December 31, 2025
Assets    
Current assets:    
Cash and cash equivalents 1,018   1,024  
Short-term investments 27    
Trade and other receivables 767   700  
Due from related parties 4   3  
Prepayments and deposits 82   78  
Inventories 185   174  
     
Total current assets 2,083   1,980  
     
Non-current assets:    
Property and equipment, including right-of-use 3,614   3,674  
Other non–current assets 1,540   1,539  
     
Total non-current assets 5,154   5,213  
Total assets 7,236   7,193  
     
Liabilities    
Current liabilities:    
Loans and borrowings, including leases 456   451  
Others 2,755   2,645  
Total current liabilities 3,211   3,096  
     
Non-current liabilities:    
Loans and borrowings, including leases 3,528   3,604  
Others 1,078   1,085  
     
Total non-current liabilities 4,606   4,689  
Total liabilities 7,817   7,785  
     
Total equity (deficit) (581 ) (592 )
     
Total equity and liabilities 7,236   7,193  
     
The Company has used the US dollar as the presentation currency for these consolidated financial statements, which is also its functional currency.

 
Grupo Aeroméxico, S.A.B. de C.V. and Subsidiaries
Consolidated Statements of Cash Flows (Unaudited)
 
Three Months Ended March 31,
 
(USD Millions)
 
2026
 
2025
 
Var $
       
Operating cash 309   318   (9
)
 
       
Operational assets and liabilities (29)   (57)   27  
       
Cash generated from (required by) operating activities 279   261   18  
       
Income tax paid (16)   (28)   12  
       
Interest paid (63)   (52)   (11)  
       
Net cash from (used in) operating activities 201   181   19  
       
Acquisition of properties and equipment and intangible assets (70)   (74)   4  
Others (26)   (3)   (23)  
Net cash used in investing activities (96
)
  (76
)
  (20
)
 
       
Net cash from (used in) financing activities (108
)
  (107
)
  (2
)
 
       
Effect of exchange rate fluctuations on cash held (3)   (1)   (2)  
       
Net increase (decrease) in cash and cash equivalents (6
)
  (2
)
  (4
)
 
       
Cash and cash equivalents:      
At beginning of the period 1,024   842   182  
At end of the period 1,018   840   178  

The Company has used the US dollar as the presentation currency for these consolidated financial statements, which is also its functional currency.

 
FINANCIAL AND OPERATIONAL INDICATORS



Financial KPIs Three Months Ended

 March 31
1Q26 1Q25 Var. %
Total revenue 1,341 1,184 13.3%
Passenger revenue 1,212 1,072 13.1%
Adjusted EBITDAR(1) 336 320 5.0%
Adjusted EBITDAR margin(1) (% of Revenue) 25% 27% 2.0 p.p.
Total operating income (loss) 142 142 -0.1%
Operating Margin (% of Revenue) 11% 12% -1.4 p.p.
Net Income (loss) 11 22 -51.0%
Net Income (loss) Margin (% of Revenue) 1% 2% -1.1 p.p.
Operating Indicators 1Q26 1Q25 Var. %
Total ASMs (millions) 8,596 8,697 (1.2)%
Total RPMs (millions) 7,255 7,158 1.4%
Load factor on scheduled flights (%) 84.4% 82.3%  2.1 p.p
Passengers (‘000) 5,791 5,877 (1.5)%
On-Time departure performance within 15 minutes (%) 91.7% 92.7%  (1.0) p.p
Total liters of fuel (‘000) 410,974 421,858 (2.6)%
Yield (USD cents) (2) 9.0 8.3 8.7%
Total revenue / ASM (USD cents) 15.6 13.6 14.6%
Passenger revenue / ASM (USD cents)(2) 12.2 11.0 11.4%
Total cost / ASM (USD cents) 13.8 11.9 16.0%
Total cost excluding fuel / ASM (USD cents) 10.2 8.6 17.8%
Other Indicators 1Q26 1Q25 Var. %
Fuel cost per liter (USD cents) 77 68 13.1%
FX close(3) 18.07 20.32 (11.1%)
FX average(3) 17.58 20.43 (14.0%)

Figures may not sum to total due to rounding.

1) Adjusted EBITDAR and Adjusted EBITDAR margin are non-IFRS measures and have limitations as analytical tools, and you should not consider them in isolation, or as a substitute for analysis of the Company’s results as reported under IFRS. See Annex A for the definition of Aeroméxico’s non-IFRS measures and a reconciliation to the nearest IFRS measure.
2) Estimated as passenger revenues (excluding ancillaries) divided by total RPMs.
3) Source: Company with information from Banxico.






Annex A on Non-IFRS Financial Measures

In addition to disclosing financial results prepared in accordance with IFRS, the Company discloses information regarding Adjusted EBITDAR, Adjusted EBITDAR Margin, Adjusted Net Debt and Net Leverage Ratio, which are non-IFRS measures. The Company believes that these measures are useful indicators of its operational performance. These known performance measurements in the aviation industry are frequently used by investors, stock analysts and others who are interested in comparing the operational performance of companies in its industry.

The Company defines Adjusted EBITDAR as profit or loss for the period before income tax expense (benefit), depreciation and amortization, net finance cost, and impairment (reversal), before aircraft leasing expense, in light of the non-recurring nature of this item. The Company considers Adjusted EBITDAR to be solely a valuation metric, not a performance metric. The Company defines Adjusted EBITDAR Margin as Adjusted EBITDAR divided by total revenue for the period. The Company defines Adjusted Net Debt as total loan and borrowings, including leases, minus cash and cash equivalents. The Company defines Net Leverage Ratio as Adjusted Net Debt Ratio divided by Adjusted EBITDAR for the period.

All of the above-mentioned non-IFRS financial measures have limitations as analytical tools, and you should not consider them in isolation, or as a substitute for analysis of the Company’s results as reported under IFRS. Some of these limitations are: (i) they do not reflect the Company’s cash expenditures, or future requirements for capital expenditures or contractual commitments; (ii) they do not reflect changes in, or cash requirements for, its working capital needs; (iii) they do not reflect the Company’s cash requirements necessary to service interest or principal payments on the Company’s debt; (iv) although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and they do not reflect any cash requirements for such replacements; (v) they do not adjust for all non-cash income or expense items that are reflected in the Company’s consolidated statements of profit or loss and other comprehensive income; (vi) they do not reflect the impact of all non-recurring items; and (vii) other companies in the Company’s industry may calculate these measures, or similarly titled measures, differently than the Company does, limiting their usefulness as comparative measures.

Reconciliations of each of these historical measures, and to the extent applicable, forward-looking measures to the most directly comparable IFRS measure are below. No reconciliation of the forecasted amounts of Adjusted EBITDAR Margin, as incrementally adjusted, and revenue, as incrementally adjusted, for fiscal 2026 is included in this release because we are unable to quantify certain amounts that would be required to be included in the corresponding IFRS measure without unreasonable efforts, due to high variability and complexity with respect to estimating certain forward-looking amounts, and we believe such reconciliation would imply a degree of precision that would be confusing or misleading to investors.

Adjusted EBITDAR Reconciliation
Three Months Ended March 31
1Q26 1Q25 Var. %
Profit (loss) for the period 11 22 -51.0%
(+) Income tax expense (benefit) 2 6 -65.9%
(+) Depreciation and amortization (1) 190 173 9.7%
(+) Net finance cost 129 115 12.7%
(+) Impairment (reversal) NA
(+) Aircraft leasing (2) 4 5 11.6%
Adjusted EBITDAR

(3)
336 320 5.0
%

Figures may not sum to total due to rounding.

1) Depreciation and amortization expense as presented in our profit or loss.
2) Aircraft leasing is comprised of short-term rentals of flight equipment, including subject to PBH period.
3) Adjusted EBITDAR is a non-IFRS measures and have limitations as analytical tools, and you should not consider them in isolation, or as a substitute for analysis of the Company’s results as reported under IFRS.

Adjusted Net Debt Reconciliation March 31, 2026 December 31, 2025
Total loans and borrowings, including leases 3,984 4,055
(-) Cash and cash equivalents 1,018 1,024
(-) Short-term investments 27
= Adjusted Net Debt

(1)
2,939 3,031

Figures may not sum to total due to rounding.

1) Adjusted Net Debt is a non-IFRS measures and has limitations as analytical tools, and you should not consider it in isolation, or as a substitute for analysis of the Company’s results as reported under IFRS.

Net Leverage Ratio Reconciliation (Adjusted Net Debt / Last Twelve Months Adjusted EBITDAR) March 31, 2026 December 31, 2025
Adjusted Net Debt (1) 2,939 3,031
Last Twelve Months Adjusted EBITDAR (1) 1,688 1,672
= Net Leverage Ratio

(1)
1.7x 1.8x

Figures may not sum to total due to rounding

1) Adjusted Net Debt, Adjusted EBITDAR and Net Leverage Ratio are non-IFRS measures and have limitations as analytical tools, and you should not consider them in isolation, or as a substitute for analysis of the Company’s results as reported under IFRS.

CONTACT:  Investor Relations  [email protected]
  Corporate Communications [email protected]



Northern Trust Declares Quarterly Dividends on Common and Preferred Stock

Northern Trust Declares Quarterly Dividends on Common and Preferred Stock

CHICAGO–(BUSINESS WIRE)–
Northern Trust Corporation (Nasdaq: NTRS), holding company of The Northern Trust Company, has declared a quarterly cash dividend of $0.80 per share on its common stock ($1.66-2/3 par value), payable on July 1, 2026, to holders of record at 5:00 p.m., Chicago time, on June 5, 2026.

Northern Trust Corporation also declared a cash dividend of $293.75 per share of its Series E non-cumulative perpetual preferred stock (resulting in a distribution of $0.29375 per depositary share), payable on July 1, 2026, to holders of record at 5:00 p.m., Chicago time, on June 15, 2025.

About Northern Trust

Northern Trust Corporation (Nasdaq: NTRS) is a leading provider of wealth management, asset servicing, asset management and banking services to corporations, institutions, affluent families and individuals. Founded in Chicago in 1889, Northern Trust has a global presence with offices in 24 U.S. states and Washington, D.C., and across 22 locations in Canada, Europe, the Middle East and the Asia-Pacific region. As of March 31, 2026, Northern Trust had assets under custody/administration of US$18.6 trillion, and assets under management of US$1.8 trillion. For more than 135 years, Northern Trust has earned distinction as an industry leader for exceptional service, financial expertise, integrity and innovation. Visit us on northerntrust.com. Follow us on Instagram @northerntrustcompany or Northern Trust on LinkedIn.

Northern Trust Corporation, Head Office: 50 South La Salle Street, Chicago, Illinois 60603 U.S.A., incorporated with limited liability in the U.S. Global legal and regulatory information can be found at https://www.northerntrust.com/terms-and-conditions.

Media Contact:

John O’Connell

Northern Trust

+1 312 444 2388

John_O’[email protected]

http://www.northerntrust.com

KEYWORDS: Illinois United States North America

INDUSTRY KEYWORDS: Banking Asset Management Professional Services Finance

MEDIA:

Logo
Logo

Gulfport Energy Schedules First Quarter 2026 Earnings Release and Conference Call

Gulfport Energy Schedules First Quarter 2026 Earnings Release and Conference Call

OKLAHOMA CITY–(BUSINESS WIRE)–
Gulfport Energy Corporation (NYSE: GPOR) announced today that it will host a teleconference and webcast to discuss its first quarter 2026 financial and operating results beginning at 9:00 a.m. ET (8:00 a.m. CT) on Wednesday, May 6, 2026. Gulfport plans to announce first quarter 2026 results on Tuesday, May 5, 2026, after market close.

The conference call can be heard live through a link on the Gulfport website, www.gulfportenergy.com. In addition, you may participate in the conference call by dialing 866-373-3408 domestically or 412-902-1039 internationally. A replay of the conference call will be available on the Gulfport website and a telephone audio replay will be available from May 6, 2026 to May 20, 2026, by calling 877-660-6853 domestically or 201-612-7415 internationally and then entering the replay passcode 13759931.

About Gulfport

Gulfport is an independent, natural gas-weighted exploration and production company focused on the exploration, acquisition and production of natural gas, crude oil and NGL in the United States with primary focus in the Appalachia and Anadarko basins. Our principal properties are located in eastern Ohio targeting the Utica and Marcellus formations and in central Oklahoma targeting the SCOOP Woodford and SCOOP Springer formations.

Investor Contact

Jessica Antle – Vice President, Investor Relations

[email protected]

405-252-4550

KEYWORDS: Oklahoma United States North America

INDUSTRY KEYWORDS: Energy Other Energy Oil/Gas

MEDIA:

Logo
Logo

Wildfire Evacuees: U-Haul Offers Disaster Relief at 49 Stores in Florida, Georgia

Wildfire Evacuees: U-Haul Offers Disaster Relief at 49 Stores in Florida, Georgia

JACKSONVILLE, Fla.–(BUSINESS WIRE)–
U-Haul® is offering 30 days of free self-storage and U-Box® container use at 49 Company facilities across most of northern Florida and southeast Georgia to residents impacted by the multiple wildfires burning across the region.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260421612658/en/

U-Haul is offering 30 days of free self-storage at 49 Company centers, primarily in northern Florida, to assist residents and evacuees impacted by multiple wildfires.

U-Haul is offering 30 days of free self-storage at 49 Company centers, primarily in northern Florida, to assist residents and evacuees impacted by multiple wildfires.

Homes and personal property are at risk from wildfires in Clay County, Putnam County and Nassau County in Florida, as well as Brantley County in Georgia.

Voluntary evacuations are in effect. More than 3,000 acres have been scorched by the merged Railroad Fire along the Clay-Putnam County line. A red flag warning remains in effect for 31 Florida counties as much of the state sits under extreme to exceptional drought conditions.

Access to self-storage units and portable storage containers is vital to the recovery process of communities after natural disasters strike.

U-Haul is ready to help anyone affected by the fires who needs a secure storage solution at no cost for one month.

The 30 days free offer applies to new self-storage and U-Box rentals and is based on availability at participating locations. The U-Box offer is for on-site storage at Company facilities; delivery is available for a modest fee.

People seeking more information on the disaster relief program or needing to arrange storage services can call their nearest regional office or visit any U-Haul-owned facility in the cities listed below:

U-Haul Co. of Jacksonville (15 Stores)

(904) 781-9404

Participating store locations: Atlantic Beach, Fernandina Beach, Jacksonville, Neptune Beach, Saint Augustine

U-Haul Co. of Tallahassee (15 Stores)

(866) 723-3056

Participating store locations: Jacksonville, Lake City, Orange Park, Middleburg, Tallahassee

U-Haul Co. of Gainesville (18 Stores)

(352) 377-7311

Participating store locations: Brooksville, Eustis, Gainesville, Hudson, Leesburg, Ocala, Spring Hill

Additional store from U-Haul Co. of Southern Georgia:

U-Haul Moving & Storage of Brunswick

3749 Altama Ave.

Brunswick, GA 31520

(912) 267-9190

In addition to its 30 days free self-storage disaster relief program, U-Haul is proud to be at the forefront of aiding communities in times of need as an official American Red Cross Disaster Responder.

For customers needing storage beyond the free period, the U-Haul 1-Year Price Lock is now available at 2,100 Company-owned facilities across the U.S. and Canada. Fixed-rate storage ensures at least 12 months with no price increase on your rental unit, and U-Haul never charges admin fees or deposits. Learn more at uhaul.com/Storage/1-Year-Price-Lock.

About U-HAUL

Founded in 1945, U-Haul is the No. 1 choice of do-it-yourself movers with more than 24,000 rental locations across all 50 states and 10 Canadian provinces. The U-Haul app makes it easy for customers to use U-Haul Truck Share 24/7 to access trucks anytime through the self-dispatch and -return options on their smartphones with our patented Live Verify technology. Our customers’ patronage has enabled the U-Haul fleet to grow to approximately 203,000 trucks, 137,400 trailers and 41,700 towing devices. U-Haul, which offers rate transparency to self-storage customers through its 1-Year Price Lock, is the third largest storage operator in North America with 1,126,800 rentable storage units and 98 million square feet of self-storage space at owned and managed facilities. U-Haul is the top retailer of propane in the U.S. and the largest installer of permanent trailer hitches in the automotive aftermarket industry. Get the U-Haul app from the App Store or Google Play.

Dillon Rosenblatt

E-mail: [email protected]

Phone: 602-263-6194

Website: uhaul.com

KEYWORDS: Florida Georgia United States North America

INDUSTRY KEYWORDS: Professional Services Philanthropy Fleet Management Social Services Automotive Commercial Building & Real Estate Construction & Property Environment Trucking Natural Disasters Transport Other Philanthropy Environmental, Social and Governance (ESG)

MEDIA:

Photo
Photo
U-Haul is offering 30 days of free self-storage at 49 Company centers, primarily in northern Florida, to assist residents and evacuees impacted by multiple wildfires.
Logo
Logo

Revolution Medicines to Present Updated Phase 1/2 Clinical Data for Daraxonrasib in First Line Metastatic Pancreatic Cancer Across Monotherapy and Combination Cohorts at the 2026 AACR Annual Meeting

REDWOOD CITY, Calif., April 21, 2026 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced updated clinical data from two Phase 1/2 trials of daraxonrasib, an oral RAS(ON) multi-selective inhibitor, in patients with previously untreated metastatic pancreatic ductal adenocarcinoma (PDAC). Data from the daraxonrasib combination cohort will be presented in a late-breaking mini-symposium, and data from the monotherapy cohort will be presented in a poster session at the American Association for Cancer Research (AACR) Annual Meeting on April 21, 2026.

Findings from both trials support daraxonrasib’s continued evaluation in the first line setting, demonstrating manageable safety and tolerability profiles along with early signs of durable antitumor activity across monotherapy and combination approaches.

“Patients with metastatic pancreatic cancer continue to face challenging outcomes,” said Eileen M. O’Reilly, M.D., Winthrop Rockefeller Endowed Chair of Medical Oncology at Memorial Sloan Kettering Cancer Center, and a key investigator for the RMC-6236-001 trial. “What I find notable about these datasets is the strength of antitumor activity observed with daraxonrasib across both monotherapy and combination therapy, along with manageable safety profiles. With longer follow up, these results further support the potential of a novel RAS-targeted therapy to meaningfully improve outcomes in frontline metastatic PDAC.”

“The activity observed with daraxonrasib in the first line setting, as both single-agent and combination therapy, represents a promising signal in this difficult-to-treat population,” said Alan Sandler, M.D., chief development officer of Revolution Medicines. “We believe these findings support continued evaluation of daraxonrasib in the ongoing Phase 3 RASolute 303 trial in patients with previously untreated metastatic PDAC.”

Daraxonrasib plus Chemotherapy as First Line Treatment for Patients with Metastatic Pancreatic Adenocarcinoma (

Abstract #LB407

)

RMC-GI-102 (NCT06445062) is a Phase 1/2 open-label, multicenter trial with multiple cohorts evaluating daraxonrasib-based combinations in patients with RAS mutant gastrointestinal tumors. The results to be presented at the AACR Annual Meeting focus on patients in the first line metastatic PDAC cohort treated with daraxonrasib plus gemcitabine and nab-paclitaxel (GnP).

As of a December 1, 2025 data cutoff, 40 patients with previously untreated RAS mutant metastatic PDAC received daraxonrasib 200 mg once daily in 28-day cycles plus GnP given on a Day 1 and Day 15 schedule. In these patients, daraxonrasib plus GnP had a manageable safety profile, and the safety profile observed for the combination regimen was consistent with the known safety findings of each respective agent. The most common Grade ≥3 treatment-related adverse events (TRAEs) were anemia (33%), decreased neutrophil count (20%), and fatigue (18%). No Grade 5 TRAEs were reported. In the trial, TRAEs led to discontinuation of daraxonrasib in 5% (n=2) of patients and of GnP in 15% (n=6) of patients. The mean dose intensity was 82% for daraxonrasib and 80% for GnP.

Daraxonrasib plus GnP showed encouraging preliminary antitumor activity in patients with previously untreated RAS mutant metastatic PDAC. In patients who had at least 18 weeks of follow up prior to the data cutoff (n=40), the confirmed objective response rate (ORR) was 58% (95% confidence interval (CI): 41, 73), including one confirmed response. Median progression-free survival (PFS) and median overall survival (OS) were not mature at the data cutoff. The Kaplan-Meier estimate for PFS at 6 months was 84% (95% CI: 68, 93) and for OS was 90% (95% CI: 76, 96).

Daraxonrasib Monotherapy as First Line Treatment for Patients With Metastatic Pancreatic Adenocarcinoma (

Abstract #LB337

)

RMC-6236-001 (NCT05379985) is a Phase 1/2 open-label, multicenter trial evaluating daraxonrasib monotherapy in patients with RAS mutant solid tumors.

As of a December 1, 2025 data cutoff, patients with previously untreated RAS mutant metastatic PDAC received daraxonrasib 300 mg daily in 21-day cycles. In these patients, the safety profile observed for daraxonrasib was generally consistent with the reported safety findings for daraxonrasib monotherapy in previously treated patients. All-grade TRAEs occurred in 95% (n=38) of patients and Grade ≥3 TRAEs occurred in 38% (n=15) of patients. The most common Grade ≥3 TRAEs reported in at least 10% of patients were rash, diarrhea, and stomatitis. No Grade 4 or 5 TRAEs were reported. The mean dose intensity was 84%.

Daraxonrasib demonstrated encouraging preliminary antitumor activity in patients with previously untreated RAS mutant metastatic PDAC, with an ORR of 47% (95% CI: 31, 64), including one complete response, and a disease control rate of 92% (95% CI: 79, 98). Median PFS and median OS data were not yet mature at the data cutoff. The Kaplan-Meier estimate for PFS at 6 months was 71% (95% CI: 53, 83) and for OS was 83% (95% CI: 67, 92).

Daraxonrasib is being evaluated in four global Phase 3 clinical trials: three in PDAC (two ongoing and one completed) and one in non-small cell lung cancer (NSCLC). The company recently announced that the pivotal Phase 3 RASolute 302 clinical trial in patients with previously treated metastatic pancreatic cancer met all primary and key secondary endpoints, including PFS and OS. In the trial, daraxonrasib demonstrated an unprecedented OS benefit in all enrolled patients (the intent to treat population), including those with tumors with and without (wild type) an identified RAS mutation.

About Pancreatic Cancer and Pancreatic Ductal Adenocarcinoma

Pancreatic cancer is one of the most lethal malignancies, characterized by its typically late-stage diagnosis, resistance to standard chemotherapy, and high mortality rate. In the U.S., recent estimates indicate that annually approximately 60,000 people will be diagnosed with pancreatic cancer, and about 50,000 people will die from this aggressive disease.1

Due to the lack of early symptoms and detection methods, approximately 80% of patients are diagnosed with PDAC at an advanced or metastatic stage. It is the most commonly RAS-addicted of all major cancers, and more than 90% of patients have tumors that harbor RAS mutations.2 Metastatic PDAC remains one of the most common causes of cancer-related deaths in the U.S., with a five-year survival rate of approximately 3%.3,4

About Daraxonrasib

Daraxonrasib (RMC-6236) is an oral, direct RAS(ON) multi-selective inhibitor with the potential to help address a broad range of cancers driven by oncogenic RAS, including PDAC, NSCLC and colorectal cancer. Daraxonrasib suppresses RAS signaling by blocking the interaction of wild-type and mutant RAS(ON) with its downstream effectors.

About Revolution Medicines, Inc.

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Additional development opportunities in the company’s pipeline focus on RAS(ON) mutant-selective inhibitors, including RMC-0708 (Q61H) and RMC-8839 (G13C). For more information, please visit www.revmed.com and follow us on LinkedIn.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this press release that are not historical facts may be considered “forward-looking statements,” including without limitation statements regarding the company’s development strategy and its ability to build or advance its portfolio and R&D pipeline; progression of clinical studies and findings from these studies, including the tolerability, safety, and potential efficacy of the company’s candidates being studied; and the potential of daraxonrasib as a therapeutic option for patients with PDAC, including the ability of daraxonrasib to meaningfully improve outcomes in frontline metastatic PDAC.

Forward-looking statements are typically, but not always, identified by the use of words such as “aims,” “anticipate,” “believe,” “estimate,” “expect,” “plan,” “potential,” “project,” “up to,” “will” and other similar terminology indicating future results. Such forward-looking statements are subject to substantial risks and uncertainties that could cause the company’s development programs, future results, performance, or achievements to differ materially from those anticipated in the forward-looking statements. Such risks and uncertainties include without limitation risks and uncertainties inherent in the drug development process, including the company’s programs’ development stages, the process of designing and conducting preclinical and clinical trials, the regulatory approval processes, the timing of regulatory filings, the challenges associated with manufacturing drug products, the company’s ability to successfully establish, protect and defend its intellectual property, other matters that could affect the sufficiency of the company’s capital resources to fund operations, reliance on third parties for manufacturing and development efforts, changes in the competitive landscape, and the effects on the company’s business of the global events, such as international conflicts or global pandemics. For a further description of the risks and uncertainties that could cause actual results to differ from those anticipated in these forward-looking statements, as well as risks relating to the business of Revolution Medicines in general, see Revolution Medicines’ Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) on February 25, 2026, and its future periodic reports to be filed with the SEC. Except as required by law, Revolution Medicines undertakes no obligation to update any forward-looking statements to reflect new information, events, or circumstances, or to reflect the occurrence of unanticipated events.

Revolution Medicines Media & Investor Contact:

[email protected]

[email protected]

____________________
1 Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12-49. doi:10.3322/caac.21820
2 Lee JK, Sivakumar S, Schrock AB, et al. Comprehensive pan-cancer genomic landscape of KRAS altered cancers and real-world outcomes in solid tumors. NPJ Precis Oncol. 2022;6(1);91. doi:10.1038/s41698-022-00334-z.
3 Halbrook CJ, Lyssiotis CA, Pasca di Magliano M, Maitra A. Pancreatic cancer: Advances and challenges. Cell. 2023;186(8):1729-1754. doi:10.1016/j.cell.2023.02.014
4 American Cancer Society. Survival Rates for Pancreatic Cancer. Available at: https://www.cancer.org/cancer/types/pancreatic-cancer/detection-diagnosis-staging/survival-rates.html. Accessed April 2026.



Mativ Announces Conference Call to Discuss First Quarter 2026 Results

Mativ Announces Conference Call to Discuss First Quarter 2026 Results

ALPHARETTA, Ga.–(BUSINESS WIRE)–
Mativ Holdings, Inc. (NYSE: MATV) today announced it will release first quarter 2026 financial results on May 6, 2026, after the market closes.

A conference call to discuss these results has been scheduled for 8:30 a.m. ET on May 7, 2026. The call can be accessed via webcast or by telephone using the information set forth below. An online replay of the call will be accessible on the Investors section of Mativ’s website at ir.mativ.com shortly after the webcast is complete.

What: Mativ First Quarter 2026 Earnings Release

When: Thursday, May 7, 2026, at 8:30 a.m. ET

Where: https://events.q4inc.com/attendee/105679634

Dial-in:

United States Toll-Free: +1-833-461-5787

International: +1-585-542-9983

Meeting ID: 105679634

Passcode: 805494

To listen to the live call, please go to the website at least 15 minutes prior to the call to register and to download and install any necessary audio software.

Thank you for your interest in Mativ. We look forward to your participation in the conference call.

Chris Kuepper, IRC

Director, Investor Relations

+1-770-569-4229

ir.mativ.com/

KEYWORDS: Georgia United States North America

INDUSTRY KEYWORDS: Natural Resources Other Manufacturing Packaging Engineering Chemicals/Plastics Other Natural Resources Manufacturing Forest Products

MEDIA: